Prognostic value of circulating tumour DNA fraction in metastatic castration-resistant prostate cancer: Insights from the ProBio trial

被引：0

作者：

Crippa, A. ^{[1
]}

Mortezavi, A. ^{[2
]}

Discacciati, A. ^{[1
]}

Karlsson, C. T. ^{[3
]}

Strijbos, M. H. ^{[4
]}

Janes, E. ^{[5
]}

Enblad, G. ^{[6
]}

Sautois, B. ^{[7
]}

Ullen, A. ^{[8
]}

Stenner-Liewen, F. ^{[9
]}

Hjalm-Eriksson, M. E. ^{[10
]}

De Maeseneer, D. J. ^{[11
]}

Schatteman, P. ^{[12
]}

Ghysel, C. ^{[13
]}

Oldenburg, J. ^{[14
]}

Lindberg, J. ^{[15
]}

Ost, P. ^{[16
]}

Eklund, M. ^{[17
]}

Gronberg, H. ^{[15
]}

De Laere, B. ^{[18
]}

机构：

[1] Karolinska Inst, Med Epidemiol & Biostat, Stockholm, Sweden

[2] Univ Hosp Basel, Dept Urol, Basel, Switzerland

[3] Umea Univ, Radiat Sci, Oncol, Umea, Sweden

[4] GZA Ziekenhuizen, Med Oncol Dept, Campus Sint Augustinus, Antwerp, Belgium

[5] Sundsvall Hosp, Dept Oncol, Sundsvall, Sweden

[6] Akad Sjukhuset Uppsala, Oncol Dept, Uppsala, Sweden

[7] Ctr Hosp Univ Sart Tilman, Dept Med Oncol, Liege, Belgium

[8] Karolinska Inst, Dept Oncol, Stockholm, Sweden

[9] Univ Spital Basel, Oncol Dept, Basel, Switzerland

[10] Capio St Gorans Hosp, Surg Dept, Stockholm, Sweden

[11] AZ Sint Lucas, Dept Med Oncol, Brugge, Belgium

[12] Onze Lieve Vrouw Clin, Urol, Campus Aalst, Aalst, Belgium

[13] AZ Sint Jan Brugge Oostende AV, Dept Urol, Brugge, Belgium

[14] Univ Oslo, Dept Oncol, Oslo, Norway

[15] Karolinska Inst, Med Epidemiol & Biostat, Stockholm, Sweden

[16] Univ Hosp Ghent, UZ Gent, Radiat Oncol, Ghent, Belgium

[17] Karolinska Inst, Med Epidemiol & Biostat, Huddinge, Sweden

[18] Karolinska Inst, Inst Med Epidemiol & Biostat, Med Epidemiol & Biostat, Solna, Sweden

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.1704

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1623P

引用

页码：S980 / S980

页数：1

共 50 条

[21] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Zhenchao Zhang
Rui Luo
William K. Kelly
Joshua Chen
Shane Donahue
Kevan Ip
Nathan R. Handley
William J. Tester
Miranda L. Tsang
Felix J. Kim
Ronald Myers
Grace Lu-Yao
Jian Gu
Jianqing Lin
Bingshan Li
Chun Wang
Hushan Yang
Prostate Cancer and Prostatic Diseases, 2024, 27 : 339 - 347
[22] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Zhang, Zhenchao
Luo, Rui
Kelly, William K.
Chen, Joshua
Donahue, Shane
Ip, Kevan
Handley, Nathan R.
Tester, William J.
Tsang, Miranda L.
Kim, Felix J.
Myers, Ronald
Lu-Yao, Grace
Gu, Jian
Lin, Jianqing
Li, Bingshan
Wang, Chun
Yang, Hushan
PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 339 - 347
[23] Metastatic castration-resistant prostate cancer
Henriques, Vanessa
Wenzel, Mike
Demes, Melanie-Christin
Koellermann, Jens
PATHOLOGE, 2021, 42 (04): : 431 - 438
[24] Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
Scher, H. I.
Armstrong, A. J.
Schonhoft, J. D.
Gill, A.
Zhao, J. L.
Barnett, E.
Carbone, E.
Lu, J.
Antonarakis, E. S.
Luo, J.
Tagawa, S.
dos Anjos, C. H.
Yang, Q.
George, D.
Szmulewitz, R.
Danila, D. C.
Wenstrup, R.
Gonen, M.
Halabi, S.
EUROPEAN JOURNAL OF CANCER, 2021, 150 : 83 - 94
[25] Circulating tumor DNA (ctDNA) and correlations with clinical prognostic factors in patients with metastatic castration-resistant prostate cancer (mCRPC).
Khalaf, Daniel
Annala, Matti
Beja, Kevin
Vandekerkhove, Gillian
Zulfiqar, Muhammad
Finch, Daygen L.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[26] Trial design for metastatic castration-resistant prostate cancer - Reply
Scher, Howard I.
Halabi, Susan
Tannock, Ian F.
Morris, Michael
Sternberg, Cora N.
Carducci, Michael A.
Eisenberger, Mario A.
Higano, Celestia
Bubley, Glenn J.
Dreicer, Robert
Petrylak, Daniel P.
Kantoff, Philip
Basch, Ethan
Kelly, Wm Kevin
Figg, William D.
Small, Eric J.
Beer, Tomasz M.
Wilding, George
Martin, Alison
Hussain, Maha
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3648 - 3649
[27] Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
Conteduca, Vincenza
Wetterskog, Daniel
Scarpi, Emanuela
Romanel, Alessandro
Gurioli, Giorgia
Jayaram, Anuradha
Lolli, Cristian
Tandefelt, Delila Gasi
Schepisi, Giuseppe
Casadei, Chiara
Wingate, Anna
Matteucci, Federica
Paganelli, Giovanni
Gonzalez-Billalabeitia, Enrique
Demichelis, Francesca
De Giorgi, Ugo
Attard, Gerhardt
BRITISH JOURNAL OF CANCER, 2020, 123 (06) : 982 - 987
[28] Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
Vincenza Conteduca
Daniel Wetterskog
Emanuela Scarpi
Alessandro Romanel
Giorgia Gurioli
Anuradha Jayaram
Cristian Lolli
Delila Gasi Tandefelt
Giuseppe Schepisi
Chiara Casadei
Anna Wingate
Federica Matteucci
Giovanni Paganelli
Enrique Gonzalez-Billalabeitia
Francesca Demichelis
Ugo De Giorgi
Gerhardt Attard
British Journal of Cancer, 2020, 123 : 982 - 987
[29] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
Danila, D. C.
Leversha, M. A.
Gonzalez-Espinoza, R.
Anand, A.
Gu, B.
Gignac, G. A.
Larson, S.
Heller, G.
Fleisher, M.
Scher, H. I.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[30] The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer
Pond, Gregory R.
Sonpavde, Guru
de Wit, Ronald
Eisenberger, Mario A.
Tannock, Ian F.
Armstrong, Andrew J.
EUROPEAN UROLOGY, 2014, 65 (01) : 3 - 6

← 1 2 3 4 5 →